Catalyst Wire Dossier Catalyst Wire Dossier

Sintilimab (Tyvyt)

sintilimab · Innovent Biologics
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Sintilimab (Tyvyt), covering 2025-01-15 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: Sintilimab in Cancer of Unknown Primary [Phase 2]

See pricing